Disease: psychiatric conditions

Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task

mycolabadmin

This study compiled data from multiple research studies to understand how classical psychedelics like LSD, psilocybin, and ayahuasca affect empathy—the ability to understand and share others’ feelings. The findings show these substances significantly increase emotional empathy, helping people feel more connected to others’ emotions. However, they don’t appear to affect cognitive empathy, which is the mental ability to understand what others are thinking. These results suggest psychedelics may have therapeutic potential for improving social connection and emotional understanding.

Read More »

N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences

mycolabadmin

Researchers studied how DMT, a powerful psychedelic drug, changes brain activity patterns and how these changes relate to what people experience. Using advanced brain imaging and network analysis, they found that DMT shifts brain activity away from large-scale network patterns toward smaller, more diverse patterns. Importantly, these brain changes directly tracked with how intensely participants reported experiencing the drug’s effects moment-to-moment.

Read More »

Pharmacokinetics of Psilocybin: A Systematic Review

mycolabadmin

This review examines how the body processes psilocybin, a compound from magic mushrooms being studied for treating depression and anxiety. When taken orally, psilocybin is quickly converted to its active form, psilocin, which reaches peak levels in the bloodstream within 1-4 hours and is eliminated mainly through urine. The body’s ability to process psilocybin involves specific liver enzymes that vary between individuals, potentially explaining why people respond differently to the same dose and why certain medications can interfere with its effects.

Read More »

Determination of Tryptamine Alkaloids and Their Stability in Psychotropic Mushrooms

mycolabadmin

Researchers analyzed the active compounds found in psychotropic mushrooms used for therapy and microdosing. They found that the amounts of these compounds vary greatly between mushroom samples and can degrade during storage. Fresh mushrooms stored in freezers degraded faster than dried mushrooms kept at room temperature in the dark, suggesting proper storage is important for maintaining therapeutic effectiveness.

Read More »
Scroll to Top